Get regular updates to your inbox.
Long-term treatment with under-the-skin injections of brodalumab safely and effectively reduced disease activity in people with axial spondyloarthritis (axSpA), according to final data from a Phase 3 trial. axSpA is a type of chronic inflammatory arthritis affecting the joints of the spine, chest, and pelvis. Ankylosing spondylitis (AS) is…
Read more
Researchers are reporting the rare case of an Andersson lesion — a destructive spinal lesion without history of trauma — in a 79-year-old man in Greece with undiagnosed ankylosing spondylitis (AS). Rarer still, the lesion likely was caused by an infection and partial paralysis. This case is believed to…
The European Medicines Agency has agreed to review UCB’s applications seeking the approval of bimekizumab for adults with active axial spondyloarthritis (axSpA). Axial spondyloarthritis is a type of inflammatory arthritis affecting the joints of the spine, chest, and pelvis. Ankylosing spondylitis (AS) is a severe type of axSpA,…
In her debut column of “Joint Journey,” Jemma Newman narrates the journey to her ankylosing spondylitis diagnosis.
Want to stay up to date on all the latest on ankylosing spondylitis? Click the link below to find more news and information.
Ankylosing spondylitis (AS) is a type of arthritis that mainly affects the joints of the spine. Inflammation of the spaces between the vertebrae causes back pain and stiffness.
There is no single specific test to diagnose AS, and many of the symptoms (such as back pain) also can be caused by other conditions. A diagnosis often involves checking for common hallmarks of AS.
Patients’ symptoms usually progress gradually over time. They may be erratic because the type and severity of the symptoms can improve, worsen, or completely stop for periods of time.
Get regular updates to your inbox.
